DPYD and cancer: Since dihydropyrimidine accumulation was previously shown to control EMT in BC [28], we tested and demonstrated the hypothesis that high TS enzymatic activity in cancer cells sustains de-differentiation and EMT via a DPYD-dependent pyrimidine catabolism.